Analyst Ratings for Cabaletta Bio Inc. (CABA)
CABA Rating Summary
CABA Price Target Summary
- Highest: $16.00 (Morgan Stanley)
- Lowest: $10.00 (Mizuho Securities)
- Average: $13.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.50 (+13.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$13.50 (+13.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/27/2023 | Morgan Stanley | Michael Ulz | Upgrade | Overweight (Equalweight) |
16.00 (3.00) |
11.12 (11.86) |
6.65% | Details |
| 12/8/2021 | Wells Fargo » Updated 1/3/2023 |
Chris M. Carey | New Coverage | Overweight (N/A) |
14.00 (4.00) |
10.68 (11.86) |
11.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
